Last reviewed · How we verify
NCT03875365
Institutional Outcome Data From Per-oral Plication of the Esophagus
trial testing POPE in Achalasia in 20 participants. Terminated before completion.
19 January 2024
Quick facts
| Lead sponsor | Mayo Clinic |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 2 October 2018 |
| Primary completion | 19 January 2024 |
| Estimated completion | 19 January 2024 |
| Sites | 3 locations across United States |
Drugs / interventions tested
- POPE
Conditions studied
- Achalasia — all drugs for Achalasia →
Sponsor
Mayo Clinic
Who can join
18 and older, any sex, with Achalasia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Researchers are reviewing and analyzing surgical and clinical outcomes of subjects who underwent POPE for end-stage achalasia, a sigmoid esophagus, or a redundant conduit that has been used to replace the esophagus. This data will help researchers determine the safety and efficacy of a novel minimally invasive treatment compared to invasive surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03875365
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Achalasia
Currently open trials in the same condition.
- NCT07496840 — Clinical Outcomes, Safety, and Effectiveness of Speedboat UltraSlim™ in Per-Oral Endoscopic Myotomy (POEM) · recruiting
- NCT07406945 — Safety and Efficacy of a Novel SpydrBlade Flexible Bipolar in POEM · NA · recruiting
- NCT06042127 — POEM-F for Achalasia International Study · NA · recruiting
- NCT05772260 — Autonomic Dysfunction and Hemodynamic Instability During Per-oral Endoscopic Myotomy · recruiting
- NCT07181070 — The Use of Indocyanine Green Fluorescence (ICG) During Laparoscopic Heller- Dor · recruiting
Other Mayo Clinic trials
Trials by the same sponsor.
- NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · NA · not yet recruiting
- NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration · not yet recruiting
- NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, · NA · not yet recruiting
- NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE) · NA · recruiting
- NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03875365 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
- Last refreshed: 11 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03875365.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing